[A comparative evaluation of the efficacy of immunocorrection in children with bronchial asthma living in ecologically contrasted regions].
Trishina. S V SV; Zorin. V N VN; Babin. Iu F IuF; Trishin. S V SV; Ruban. A V AV; Ruban. V V VV; Skorobatskiĭ. V S VS
Key Findings
- Children in polluted regions showed reduced T‑lymphocytes and lower interleukin‑2 activity.
- Thymalin’s immunomodulating effect was less noticeable in these children.
- Authors recommend repeated thymalin courses plus better environmental conditions and other selective immune stimulators.
Practical Outcomes
- For biohackers, the takeaway is that thymalin’s benefits may be limited if you’re exposed to high environmental stressors. Improving air quality or reducing pollutants could be more important than relying on the peptide alone, and combining it with other immune‑support strategies might be needed.
Summary
The study looked at kids with asthma living in polluted versus clean areas and found that those in bad environments had weaker immune cells and that the peptide thymalin didn’t work as well for them. It suggests that fixing the environment and using other immune‑boosting agents might be needed.
Abstract
Overall 50 children suffering from infectious-allergic bronchial asthma who live in ecologically contrasting regions were examined. Those children residing in unfavourable, in terms of ecological conditions, regions demonstrated diminution of the peripheral blood T-lymphocytes together with a decrease in their functional activity as well as in the activity of interleukin 2. It is in this group of children that immunomodulating effect of thymalin is less apparent. It is suggested that the relevant immune correction in such cases might be achieved through repeated courses of treatment with immunomodulating agents and rehabilitation of patients in favourable ecological conditions together with prescribing of other immunostimulators of selective action in respect of the T-link of the immunity system.
Study Information
pubmed
1995